Cargando…
The clinical, immunological and genetic features of 12 Chinese patients with STAT3 mutations
BACKGROUND: Loss-of-function (LOF) mutations in signal transducer and activator of transcription 3 (STAT3) is one of the causes of STAT3 hyperimmunoglobulin E (IgE) syndrome (STAT3-HIES), while gain-of-function (GOF) mutations in STAT3 lead to immune dysregulation diseases. We retrospectively analyz...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491347/ https://www.ncbi.nlm.nih.gov/pubmed/32944025 http://dx.doi.org/10.1186/s13223-020-00462-w |
_version_ | 1783582203448393728 |
---|---|
author | Lin, Li Wang, Ying Sun, Bijun Liu, Luyao Ying, Wenjing Wang, Wenjie Zhou, Qinhua Hou, Jia Yao, Haili Hu, Liyuan Sun, Jinqiao Wang, Xiaochuan |
author_facet | Lin, Li Wang, Ying Sun, Bijun Liu, Luyao Ying, Wenjing Wang, Wenjie Zhou, Qinhua Hou, Jia Yao, Haili Hu, Liyuan Sun, Jinqiao Wang, Xiaochuan |
author_sort | Lin, Li |
collection | PubMed |
description | BACKGROUND: Loss-of-function (LOF) mutations in signal transducer and activator of transcription 3 (STAT3) is one of the causes of STAT3 hyperimmunoglobulin E (IgE) syndrome (STAT3-HIES), while gain-of-function (GOF) mutations in STAT3 lead to immune dysregulation diseases. We retrospectively analyzed the age, common clinical symptoms, immunologic and molecular manifestations in 11 patients with LOF STAT3 mutations and 1 patient with a GOF STAT3 mutation. METHODS: Twelve patients were enrolled in our study. Serum immunoglobulin measurements, lymphocyte subset detection and whole-exome sequencing were performed. RESULTS: The median age at diagnosis of STAT3-HIES patients was 4.74 years. Eczema, recurrent respiratory infections, fevers, abscesses and Staphylococcus aureus infections were the classic manifestations. Elevated serum IgE levels are not always observed in conjunction with high eosinophil counts. A moderate viral DNA load was also measured in peripheral blood mononuclear cells. We noticed that c. 1144C>T was the most common mutation site, followed by c.1311C>A. Additionally, c.1311C>A and c. 1826G>C are two novel mutations. Eight patients achieved notable improvement after receiving intravenous immunoglobulin. CONCLUSION: We updated the current knowledge of this topic. We found an earlier median age at diagnosis, a higher survival rate, and a general lack of nonimmunological abnormalities; we also described the treatment details and novel mutations involve in STAT3-HIES and compared STAT3 LOF and GOF mutations. |
format | Online Article Text |
id | pubmed-7491347 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-74913472020-09-16 The clinical, immunological and genetic features of 12 Chinese patients with STAT3 mutations Lin, Li Wang, Ying Sun, Bijun Liu, Luyao Ying, Wenjing Wang, Wenjie Zhou, Qinhua Hou, Jia Yao, Haili Hu, Liyuan Sun, Jinqiao Wang, Xiaochuan Allergy Asthma Clin Immunol Research BACKGROUND: Loss-of-function (LOF) mutations in signal transducer and activator of transcription 3 (STAT3) is one of the causes of STAT3 hyperimmunoglobulin E (IgE) syndrome (STAT3-HIES), while gain-of-function (GOF) mutations in STAT3 lead to immune dysregulation diseases. We retrospectively analyzed the age, common clinical symptoms, immunologic and molecular manifestations in 11 patients with LOF STAT3 mutations and 1 patient with a GOF STAT3 mutation. METHODS: Twelve patients were enrolled in our study. Serum immunoglobulin measurements, lymphocyte subset detection and whole-exome sequencing were performed. RESULTS: The median age at diagnosis of STAT3-HIES patients was 4.74 years. Eczema, recurrent respiratory infections, fevers, abscesses and Staphylococcus aureus infections were the classic manifestations. Elevated serum IgE levels are not always observed in conjunction with high eosinophil counts. A moderate viral DNA load was also measured in peripheral blood mononuclear cells. We noticed that c. 1144C>T was the most common mutation site, followed by c.1311C>A. Additionally, c.1311C>A and c. 1826G>C are two novel mutations. Eight patients achieved notable improvement after receiving intravenous immunoglobulin. CONCLUSION: We updated the current knowledge of this topic. We found an earlier median age at diagnosis, a higher survival rate, and a general lack of nonimmunological abnormalities; we also described the treatment details and novel mutations involve in STAT3-HIES and compared STAT3 LOF and GOF mutations. BioMed Central 2020-07-22 /pmc/articles/PMC7491347/ /pubmed/32944025 http://dx.doi.org/10.1186/s13223-020-00462-w Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Lin, Li Wang, Ying Sun, Bijun Liu, Luyao Ying, Wenjing Wang, Wenjie Zhou, Qinhua Hou, Jia Yao, Haili Hu, Liyuan Sun, Jinqiao Wang, Xiaochuan The clinical, immunological and genetic features of 12 Chinese patients with STAT3 mutations |
title | The clinical, immunological and genetic features of 12 Chinese patients with STAT3 mutations |
title_full | The clinical, immunological and genetic features of 12 Chinese patients with STAT3 mutations |
title_fullStr | The clinical, immunological and genetic features of 12 Chinese patients with STAT3 mutations |
title_full_unstemmed | The clinical, immunological and genetic features of 12 Chinese patients with STAT3 mutations |
title_short | The clinical, immunological and genetic features of 12 Chinese patients with STAT3 mutations |
title_sort | clinical, immunological and genetic features of 12 chinese patients with stat3 mutations |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491347/ https://www.ncbi.nlm.nih.gov/pubmed/32944025 http://dx.doi.org/10.1186/s13223-020-00462-w |
work_keys_str_mv | AT linli theclinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations AT wangying theclinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations AT sunbijun theclinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations AT liuluyao theclinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations AT yingwenjing theclinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations AT wangwenjie theclinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations AT zhouqinhua theclinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations AT houjia theclinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations AT yaohaili theclinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations AT huliyuan theclinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations AT sunjinqiao theclinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations AT wangxiaochuan theclinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations AT linli clinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations AT wangying clinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations AT sunbijun clinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations AT liuluyao clinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations AT yingwenjing clinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations AT wangwenjie clinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations AT zhouqinhua clinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations AT houjia clinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations AT yaohaili clinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations AT huliyuan clinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations AT sunjinqiao clinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations AT wangxiaochuan clinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations |